Background/aims-To clarify the pathogenesis of fibrosis in inflammatory orbital diseases, we analyzed the gene expression in orbital biopsies and compared our results to those reported for idiopathic pulmonary fibrosis.
INTRODUCTION
Fibrosis is an important component of the inflammatory response. In many diseases including proliferative vitreoretinopathy, mucous membrane pemphigoid, cirrhosis, scleroderma, idiopathic pulmonary fibrosis, and retroperitoneal fibrosis, the fibrotic component of the disease is a dominant clinical feature. The ability to prevent or reverse fibrosis requires an understanding of its pathogenesis.
Exophthalmos can be due to infections, malignancies, or inflammation. The inflammatory processes include Graves disease (also known as thyroid eye disease or TED), sarcoidosis, granulomatosis with polyangiitis (GPA) (previously known as Wegener's granulomatosis), IgG4 disease, and Erdheim-Chester disease [1, 2] . Fibrosis can be a prominent component in orbital inflammation. It is considered to be an ominous prognostic finding [3] .
In order to clarify the pathogenesis of orbital inflammatory diseases, we have assembled an international consortium of orbital surgeons and ophthalmic pathologists. We have collected a library of formalin-fixed biopsies of either the lacrimal gland or orbital fat. We have scored these biopsies for fibrosis and then correlated the fibrosis score with gene expression.
Finally we compared genes with increased expression in orbital fibrosis to transcripts reportedly increased in idiopathic pulmonary fibrosis.
METHODS

Tissue and pathology review
The orbital biopsies were performed by surgeons at ten different centers from 3 continents. All biopsies were fixed in formalin. The diagnosis was made on the basis of clinical information and pathological review at the center where the biopsy was obtained. Normal, uninflamed control orbital tissue was obtained from subjects with no history of orbital disease at the time of surgery such as fat typically excised and discarded as part of routine blepharoplasty or retrobulbar fat that is snared with the eye during enucleation. The pathology was further reviewed by two of the authors (DJW and HEG). Most pathological diagnoses were accepted but in a small number of cases, an alternative diagnosis was suggested and the tissue was not included in further analysis. DJW and HEG independently scored the fibrosis as absent (0), mild (1), moderate (2), or severe (3). One pathologist based the grading scheme on the percent of tissue that was fibrotic: no fibrosis was graded as 0; up to 1/3 of the specimen containing fibrosis was graded as mild (1); 1/3 to 2/3 of the specimen containing fibrosis was graded as moderate (2) ; and greater than 2/3 of the specimen containing fibrosis was graded as severe (3) . The other pathologist graded the tissue more qualitatively overall as displaying no fibrosis versus mild, moderate or severe fibrosis.
Microarray
All tissue was sent to Oregon Health & Science University, Portland, Oregon, where RNA was extracted. cDNA was synthesized from the RNA and hybridized in two batches to Affymetrix U 133 plus 2.0 arrays, which include about 54,000 probe sets. The methodology for the RNA extraction and microarray have been previously described [4] . Further, we have reported on the RNA quality (Rosenbaum et al., manuscript submitted) and the correlation between our array data and quantitative PCR [5] .
Statistical methods
Each batch of Affymetrix cel files of a tissue type was preprocessed by Robust Multiarray Analysis separately [6] . Then, a linear regression model was fitted to the preprocessed data to estimate trend in intensity with respect fibrosis score while accounting for batch effects, disease type, age and sex to all data of a tissue type independently. To fit the model, we used RUVinv in conjunction with empirical Bayes and false discovery rate adjustment for multiple test corrections [7] . These methods are available in ruv and limma packages of R Statistical Computing Environment (http://www.r-project.org). For negative controls, we used the human housekeeping genes reported in Eisenberg and Levanon (2003) [8] .
RESULTS
We analyzed 150 biopsies including 85 from orbital fat and 65 from the lacrimal gland. The 85 orbital biopsies were obtained from 82 subjects with two biopsies read from 3 subjects. The 65 lacrimal biopsies were obtained from 56 subjects. The lacrimal biopsies included from two subjects who provided two separate tissue blocks and 7 subjects for whom two tissues from the same block were independently scored. Table 1 shows the age, gender, and number of biopsies for each diagnosis for the orbit and lacrimal gland respectively. Each pathologist scored the tissue for fibrosis independently using a 0 to 3 scale. All except nine normal control tissues were scored by both pathologists. The scores were averaged. For 64 lacrimal gland biopsies scored by both pathologists, 20 received an identical score (31.3%). In 35 instances (54.7%) the scores differed by one. In 9 instances, the scores differed by two (14.1%). For the orbital biopsies, 77 biopsies were scored by both pathologists. In 38 instances (49.3%), the scores were identical. Thirty-one times the scores differed by one (40.3%) and 8 times the scores differed by two (10.4%). The average fibrosis scores for diseases affecting orbital fat are shown in Figure 1A . The greatest degree of fibrosis was noted among subjects with GPA (p<0.0001 relative to healthy controls). Subjects with NSOI (p<0.002) or sarcoidosis (p=0.005) also demonstrated significantly more fibrosis than what was detected in control tissue, although each value was significantly less than for GPA (p<0.01). In contrast, patients with TED had an average fibrosis score that did not differ from controls.
Fibrosis scores for lacrimal gland diseases are also shown in Figure 1A . In contrast to inflammation affecting orbital fat, none of the disease processes resulted in fibrosis that differed statistically from the healthy controls. However, we only had a single lacrimal gland with the diagnosis of GPA. Figure 1B shows the frequency scores for fibrosis for each tissue site. The values should not be compared directly because the frequency for specific diagnoses differed between the tissues. However, it is apparent that a fibrosis score of 3 was far more likely to be scored in disease affecting orbital adipose tissue.
We then generated a list of transcripts that correlated with the scores of fibrosis in the orbit (FDR <0.05) while accounting for batch effects, disease type, age and sex. This is shown in Tables 2 and 3 with probe sets indicating increased and decreased expression, respectively. It includes 73 probe sets. Several of these code for proteins that are strongly implicated in fibrosis [9] including several types of collagen, thrombospondin, lumican, and fibronectin. With one exception, we were not able to correlate increased transcript expression with fibrosis within the lacrimal gland, a result that we attribute to the relative lack of fibrosis in that tissue. The only exception was an increase in nuclear-pore complex interacting proteinlike 2.
Fibrosis in specific tissues might be regulated by unique mediators, or it could be that there is substantial overlap between fibrosis within the orbit and fibrosis in other tissues. In order to test this latter hypothesis, we compared the list of transcripts increased in orbital disease with a list previously reported for idiopathic pulmonary fibrosis [9] . As shown in Table 4 , many transcripts up regulated in the orbit affected by fibrosis have also been detected as up regulated in idiopathic pulmonary fibrosis.
DISCUSSION
Fibrosis is a characteristic feature of many inflammatory diseases. We believe that our study is the first to compare the likelihood of fibrosis among various forms of orbital disease. Our , so it should not be surprising that this entity is also associated with fibrosis. On the other hand, fibrosis was minimal among patients with TED. We anticipated that fibrosis would also accompany disease in the lacrimal gland, but our data indicate that fibrosis is generally mild in lacrimal specimens and statistically the fibrosis from diseased, lacrimal tissue did not differ from fibrosis in healthy controls.
IgG4 related disease has recently been defined as a multisystem disease associated with storiform fibrosis [10] . IgG4 related disease is well described within the orbit [11] [12] [13] [14] . We recently reported on the prevalence of IgG4 staining in tissue from patients with orbital inflammatory disease [4] . We found only a slight correlation between the degree of fibrosis and IgG4 staining. Further, we found that many patients with GPA, NSOI, or sarcoidosis had IgG4 staining in their orbital tissue [4] . We did not specifically investigate the role of IgG4 in the present study, but the majority of the tissues described in this present report were included in our previous report on IgG4 [4] , and none of subjects in the prior report had a multisystem disease that could be classified as IgG4 related disease.
The two pathologists scoring fibrosis in tissue for this project agreed in only a minority of instances, 31% for lacrimal gland and 49% for orbital adipose tissue. In 14% and 10% for lacrimal gland and orbital fat respectively, the pathologists differed by a score of two. In fact, one of the pathologists who scored 9 lacrimal gland biopsies twice (because two separate blocks were evaluated) provided discordant scores 8 of the 9 instances. The intraobserver and inter-observer discrepancies could result from the subjective nature of the scoring system as well as from sampling error. The pathologists accurately recognized fibrosis since tissue with greater fibrosis expressed transcripts associated with fibrosis in another tissue, the lung. We speculate that a fibrosis score based on transcript expression might eventually be standard in biopsied tissue because it can be quantified and would minimize the sampling errors that confront a histopathologist.
We noted more fibrosis in orbital fat than in lacrimal specimens. A possible explanation for this is that the adipocytes themselves contribute to fibrosis. For example, the adipokines, leptin and adiponectin, have been implicated in hepatic fibrosis [15] . In skin affected by scleroderma, adipocytes reportedly demonstrate the potential to transform into myofibroblasts that are a critical part of the fibrosing process [16] . Future studies should compare the levels of adipokines in the lacrimal gland versus the anterior orbit as these cytokines might represent a potential therapeutic target.
The transcripts which we found to be up regulated in association with fibrosis include many that code for proteins generally implicated in fibrosis including collagens, fibronectin, and thrombospondin. This suggests that pathological grading of fibrosis has an expected molecular correlate with gene expression and it validates the histopathological interpretation. The finding of overlapping, up regulated genes in fibrosis affecting the lung and orbit also supports the validity of the technique and indicates that fibrosis in diverse tissues must share common elements in pathogenesis. An analysis of gene expression in fibrosing diseases holds the promise to discover novel targets for pharmacotherapy. Orbital adipose tissue from subjects with GPA had the highest fibrosis scores. A: Orbital adipose and lacrimal gland fibrosis scores for each disease group (mean ± standard deviation). B: The distribution of fibrosis scores relative to the site of biopsy. Table 4 Genes with increased expression in orbital fibrotic disease (Table 2) in common with genes with increased expression in idiopathic pulmonary fibrosis [9] . 
